Campbell Soup Co. vs DexCom, Inc. — how do they compare? Campbell Soup Co. trades at $22.71 (market cap $6.78B), while DexCom, Inc. trades at $89.2 (market cap $33.79B). The key difference: DexCom, Inc. is far larger — about 5× Campbell Soup Co.'s market cap, and Campbell Soup Co. pays a 6.87% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| CPB | DXCM | |
|---|---|---|
Market Cap | $6.78B | $33.79B |
Sector | Consumer Staples | Health |
52-Week High | $34.03 | $89.53 |
52-Week Low | $20.00 | $54.84 |
Enterprise Value | $13.38B | $33.24B |
Dividend Yield | 6.87% | — |
Trailing returns across standard periods
With a history that dates back around 150 years, Campbell Soup is now a leading manufacturer and marketer of branded convenience food products, most notably soup. The firm's product assortment includes well-known brands like Campbell's, Pace, Prego, Swanson, V8, and Pepperidge Farm. Following the sale of its international snacking operations, which wrapped in calendar 2019, the firm derives nearly all of its sales from its home turf. Campbell has made a handful of acquisitions to reshape its product mix the past few years, including the tie-up with Snyder's-Lance (completed in March 2018), which enhances its exposure to the faster-growing on-trend snack food aisle, complementing its Pepperidge Farm lineup.
Read more on CPB →Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →